Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ricacell for Alopecia Phase 1/2 Study
jRCTb030250640Phase 2Recruiting
- Start
- Jan 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Ricacell in alopecia areata. Primary endpoint: Primary safety endpoints. Started Jan 2026; status: recruiting.
02
Drugs
Ricacell
03
Conditions
alopecia areata
Beyond the preview
Go deeper on jRCTb030250640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb030250640.